Table 4.
Receiver operating characteristic area under the curve (95% confidence intervals) for prediction of outcome in high risk women, using CVF elafin concentration stratified by gestation at sampling, after exclusion of samples taken once prophylactic intervention had been initiated.
| Outcome | Elafin receiver operating characteristic area under the curve (95% confidence interval) | |||
|---|---|---|---|---|
| Gestation category (weeks+days) | ||||
| 10–13+6 | 14–15+6 | 16–19+6 | 20–24+0 | |
| Cervical shortening < 25 mm | 0.60 (0.53–0.66) | 0.48 (0.42–0.55) | 0.49 (0.43–0.56) | 0.53 (0.46–0.60) |
| sPTB < 37 w | 0.49 (0.42–0.56) | 0.48 (0.41–0.55) | 0.48 (0.41–0.55) | 0.52 (0.44–0.59) |
| sPTB < 34 w | 0.63 (0.56–0.70) | 0.61 (0.54–0.67) | 0.57 (0.50–0.63) | 0.64 (0.58–0.71) |
| PPROM | 0.54 (0.47–0.61) | 0.52 (0.45–0.59) | 0.49 (0.42–0.56) | 0.61 (0.53–0.67) |
| Objective infection | 0.49 (0.42–0.56) | 0.49 (0.42–0.55) | 0.50 (0.43–0.56) | 0.53 (0.46–0.60) |
| Fetal adverse outcomes | 0.60 (0.53–0.67) | 0.50 (0.44–0.58) | 0.48 (0.42–0.55) | 0.52 (0.45–0.59) |
Values in bold are statistically significant at p < 0.05.